检验医学与临床
檢驗醫學與臨床
검험의학여림상
JOURNAL OF LABORATORY MEDICINE AND CLINICAL SCIENCES
2014年
14期
1927-1928
,共2页
近视%超声乳化%白内障%晶体植入术
近視%超聲乳化%白內障%晶體植入術
근시%초성유화%백내장%정체식입술
myopia%phacoemlsification%cataract%lens implantation
目的:观察采用白内障超声乳化联合人工晶体植入术治疗超高度轴性近视合并白内障患者的临床疗效。方法对63例(95眼)超高度轴性近视合并白内障患者行超声乳化人工晶体植入术,术后随访3个月,记录视力及并发症情况。结果手术后3个月最佳矫正视力大于或等于0.6占49%,最佳矫正视力大于或等于0.3占79%。最佳矫正视力小于0.3占21%,最佳矫正视力小于0.05占7%。术前与术后最佳矫正视力比较,差异有统计学意义(t=11.238,P<0.05)。结论白内障超声乳化联合人工晶体植入术治疗超高度轴性近视合并白内障是安全有效的。
目的:觀察採用白內障超聲乳化聯閤人工晶體植入術治療超高度軸性近視閤併白內障患者的臨床療效。方法對63例(95眼)超高度軸性近視閤併白內障患者行超聲乳化人工晶體植入術,術後隨訪3箇月,記錄視力及併髮癥情況。結果手術後3箇月最佳矯正視力大于或等于0.6佔49%,最佳矯正視力大于或等于0.3佔79%。最佳矯正視力小于0.3佔21%,最佳矯正視力小于0.05佔7%。術前與術後最佳矯正視力比較,差異有統計學意義(t=11.238,P<0.05)。結論白內障超聲乳化聯閤人工晶體植入術治療超高度軸性近視閤併白內障是安全有效的。
목적:관찰채용백내장초성유화연합인공정체식입술치료초고도축성근시합병백내장환자적림상료효。방법대63례(95안)초고도축성근시합병백내장환자행초성유화인공정체식입술,술후수방3개월,기록시력급병발증정황。결과수술후3개월최가교정시력대우혹등우0.6점49%,최가교정시력대우혹등우0.3점79%。최가교정시력소우0.3점21%,최가교정시력소우0.05점7%。술전여술후최가교정시력비교,차이유통계학의의(t=11.238,P<0.05)。결론백내장초성유화연합인공정체식입술치료초고도축성근시합병백내장시안전유효적。
Objective To evaluate the therapeutic effect of phacoemlsification and intraocular lens implantation in the treatment of axial myopia combined with cataract .Methods Phacoemlsification and intraocular lens implanta-tion was performed in 95 eyes of 63 patients .The postoperative effects were observed .Results The proportion of pa-tients with postoperative corrected vision of at least 0 .6 ,at least 0 .3 ,less than 0 .3 and less than 0 .05 were 49% , 79% ,21% and 7% .Corrected visions detected before and after operation were with statistical difference (t=11 .238 , P<0 .05) .Conclusion Combination of phacoemlsification and intraocular lens implantation might be safe and effec-tive for the therapy of axial myopia combined with cataract .